SA522432879B1 - صور متعددة الأشكال من مركب ترايازول مضاد للفطريات pc945 - Google Patents

صور متعددة الأشكال من مركب ترايازول مضاد للفطريات pc945

Info

Publication number
SA522432879B1
SA522432879B1 SA522432879A SA522432879A SA522432879B1 SA 522432879 B1 SA522432879 B1 SA 522432879B1 SA 522432879 A SA522432879 A SA 522432879A SA 522432879 A SA522432879 A SA 522432879A SA 522432879 B1 SA522432879 B1 SA 522432879B1
Authority
SA
Saudi Arabia
Prior art keywords
polymorphic
images
triazole compound
antifungal triazole
antifungal
Prior art date
Application number
SA522432879A
Other languages
Arabic (ar)
English (en)
Inventor
جامي مارشال،
جوليان نورثين،
كريستوفر جون واليس،
سوزان بوتار،
جيرالد ستيل،
اسامة سليمان،
جون ميكيتوك،
Original Assignee
بولموسيد ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by بولموسيد ليمتد filed Critical بولموسيد ليمتد
Publication of SA522432879B1 publication Critical patent/SA522432879B1/ar

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
SA522432879A 2019-12-06 2022-06-05 صور متعددة الأشكال من مركب ترايازول مضاد للفطريات pc945 SA522432879B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1917867.2A GB201917867D0 (en) 2019-12-06 2019-12-06 Polymorphs
PCT/GB2020/053107 WO2021111142A1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945

Publications (1)

Publication Number Publication Date
SA522432879B1 true SA522432879B1 (ar) 2025-01-26

Family

ID=69171938

Family Applications (1)

Application Number Title Priority Date Filing Date
SA522432879A SA522432879B1 (ar) 2019-12-06 2022-06-05 صور متعددة الأشكال من مركب ترايازول مضاد للفطريات pc945

Country Status (26)

Country Link
US (2) US12491182B2 (https=)
EP (2) EP4509179A3 (https=)
JP (1) JP2023505227A (https=)
KR (1) KR20220110726A (https=)
CN (1) CN114746415B (https=)
AU (1) AU2020397613A1 (https=)
BR (1) BR112022006259A2 (https=)
CA (1) CA3155829A1 (https=)
CL (1) CL2022001464A1 (https=)
CO (1) CO2022007808A2 (https=)
DK (1) DK4069690T3 (https=)
ES (1) ES3000984T3 (https=)
FI (1) FI4069690T3 (https=)
GB (1) GB201917867D0 (https=)
HR (1) HRP20250042T1 (https=)
HU (1) HUE069799T2 (https=)
IL (1) IL293401A (https=)
LT (1) LT4069690T (https=)
MX (1) MX2022006654A (https=)
PL (1) PL4069690T3 (https=)
PT (1) PT4069690T (https=)
RS (1) RS66401B1 (https=)
SA (1) SA522432879B1 (https=)
SI (1) SI4069690T1 (https=)
SM (1) SMT202400514T1 (https=)
WO (1) WO2021111142A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3227277B1 (en) 2014-12-05 2020-02-05 Pulmocide Limited Antimycotic compound
CN117510488B (zh) * 2022-07-28 2025-12-05 博瑞制药(苏州)有限公司 一种硫酸艾沙康唑的制备方法
CN117330660A (zh) * 2023-09-14 2024-01-02 广州医科大学附属第一医院(广州呼吸中心) Uplc-ms/ms联用检测艾沙康唑的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
DE3852477T2 (de) 1987-11-20 1995-05-04 Schering Corp Tri- und tetrasubstituierte Oxetane und Tetrahydrofurane und deren Zwischenprodukte.
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
PL181193B1 (pl) 1993-12-21 2001-06-29 Schering Corp Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
HUP9701690A3 (en) 1995-06-02 1998-04-28 Schering Corp Kenilwort Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
EP1372394A1 (en) 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US9346791B2 (en) 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
EP3227277B1 (en) 2014-12-05 2020-02-05 Pulmocide Limited Antimycotic compound

Also Published As

Publication number Publication date
US20230028714A1 (en) 2023-01-26
ES3000984T3 (es) 2025-03-04
SI4069690T1 (sl) 2025-03-31
BR112022006259A2 (pt) 2022-06-21
CO2022007808A2 (es) 2022-06-30
CN114746415B (zh) 2025-04-11
CN114746415A (zh) 2022-07-12
US12491182B2 (en) 2025-12-09
MX2022006654A (es) 2022-09-07
DK4069690T3 (da) 2025-01-20
EP4509179A2 (en) 2025-02-19
LT4069690T (lt) 2025-01-10
KR20220110726A (ko) 2022-08-09
SMT202400514T1 (it) 2025-01-14
PL4069690T3 (pl) 2025-03-10
GB201917867D0 (en) 2020-01-22
EP4509179A3 (en) 2025-02-26
EP4069690B1 (en) 2024-11-13
HUE069799T2 (hu) 2025-04-28
RS66401B1 (sr) 2025-02-28
US20260060980A1 (en) 2026-03-05
HRP20250042T1 (hr) 2025-03-14
EP4069690A1 (en) 2022-10-12
PT4069690T (pt) 2024-12-13
WO2021111142A1 (en) 2021-06-10
CA3155829A1 (en) 2021-06-10
JP2023505227A (ja) 2023-02-08
CL2022001464A1 (es) 2023-03-24
FI4069690T3 (fi) 2025-01-21
IL293401A (en) 2022-07-01
AU2020397613A1 (en) 2022-06-02

Similar Documents

Publication Publication Date Title
SA522432879B1 (ar) صور متعددة الأشكال من مركب ترايازول مضاد للفطريات pc945
DK4055021T3 (da) Heterocykliske rip1-inhiberende forbindelser
HK1253073A1 (zh) 抗真菌化合物
ECSP21088515A (es) Compuestos de pirrolidina
IL308421A (en) substituted heterocyclic compounds
EP3919055A4 (en) HETEROCYCLIC COMPOUND
EA202091505A1 (ru) Триазолазолы циклогексильной кислоты в качестве антагонистов lpa
EP4066893A4 (en) HETEROCYCLIC COMPOUND
EP4293025C0 (en) COMPOSED WITH 4-AMINOQUINAZOLINE
IL308422A (en) substituted heterocyclic compounds
MD4010330T2 (ro) Derivați ai chinolinei ca inhibitori ai protein kinazei
ZA202101487B (en) Novel compounds
IL320185A (en) Heterocyclic compound
JOP20200030B1 (ar) مركب خماسي الحلقة
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
IL288782B1 (en) Sustained-release alpha-ketoglutarate preparations
GB201915191D0 (en) Novel heterocyclic compounds
EP4166551A4 (en) Triazolone compound
EP4006037A4 (en) HETEROCYCLIC COMPOUND
KR102208303B9 (ko) 유기금속 화합물 공급 장치
EP3733682A4 (en) INNOVATIVE COMPOUND FROM ALLULOSE
EP4509504A4 (en) BENZOTRIAZOLE COMPOUND
GB201910664D0 (en) Novel forms of compound
AR125853A2 (es) Composición farmacéutica de una sal hemisulfato de un compuesto nucleotídico
EP4046688A4 (en) HETEROCYCLIC COMPOUND